| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/01/2012 | CN101528709B 对痕量胺相关受体有亲和性的氨基甲基-2-咪唑类 The trace amine associated receptors have affinity for the amino-methyl-2-imidazole |
| 02/01/2012 | CN101522638B 哒嗪酮衍生物 Pyridazinones |
| 02/01/2012 | CN101511827B 作为免疫调制剂的吡啶-4-基衍生物 As immunomodulating agents pyridin-4-yl derivative |
| 02/01/2012 | CN101501031B 作为孕酮受体（pr）调节剂的噁唑烷酮衍生物 As progesterone receptor (pr) modulators oxazolidinone derivative |
| 02/01/2012 | CN101485660B α-(8-喹啉氧基)单取代酞菁锌抗肿瘤的用途 α- (8- quinolyloxy) mono-substituted zinc phthalocyanine use of antineoplastic |
| 02/01/2012 | CN101468167B 一种治疗小儿肺炎的中药组合物及其制备方法 A method of treating children with pneumonia Chinese medicine composition and its preparation method |
| 02/01/2012 | CN101467991B 烯丙基半胱氨酸及其类似物在制备治疗心肌损伤药物中的用途 Allyl cysteine and its analogues in the treatment of myocardial injury preparation of a medicament for |
| 02/01/2012 | CN101445468B 对氨基苯甲酸拟二肽酯及其制备方法和应用 Ethanol intends dipeptide ester and preparation method and application |
| 02/01/2012 | CN101439182B 一种生长抑素受体介导的肿瘤靶向药物组合物 One kind of somatostatin receptor-mediated tumor targeting pharmaceutical composition |
| 02/01/2012 | CN101431995B 稳定的维生素c组合物 Stable vitamin c composition |
| 02/01/2012 | CN101426806B 作为选择性黄体酮受体调节剂的氧杂-甾族衍生物 As selective progesterone receptor modulators oxa - steroid derivative |
| 02/01/2012 | CN101411704B 一类嘧啶取代苯丙酸化合物在制备预防和/或治疗糖尿病药物中的用途 A class of substituted phenylpropionic acid pyrimidine compounds useful for preventing and / or treatment of diabetes, in the manufacture of a medicament |
| 02/01/2012 | CN101390868B 一种植物多糖及其制备方法和用途 A plant polysaccharides and their preparation and use |
| 02/01/2012 | CN101366703B 奥美拉唑肠溶微丸制剂及制备方法 Enteric coated formulation and preparation methods |
| 02/01/2012 | CN101347408B 青藤碱静脉输液制剂 Sinomenine intravenous infusion formulations |
| 02/01/2012 | CN101337987B 一种用于抗白内障的靶蛋白 An anti-cataract target protein |
| 02/01/2012 | CN101316591B 喹啉类化合物及其制药用途 Quinoline compounds and their pharmaceutical use |
| 02/01/2012 | CN101273045B 7-[2-[4-(6-氟-3-甲基-1,2-苯并异*唑-5-基)-1-哌嗪基]乙基]-2-(1-丙炔基)-7H-吡唑-[4,3-e]-[1,2,4]-三唑-[1,5-c]嘧啶-5-胺 7- [2- [4- (6-fluoro-3-methyl-1,2-benzisoxazol * 5-yl) -1-piperazinyl] ethyl] -2- (1-propynyl yl) -7H- pyrazolo - [4,3-e] - [1,2,4] - triazolo - [1,5-c] pyrimidine-5-amine |
| 02/01/2012 | CN101264090B 一种治疗牙疼的药物 A method of treating toothache medicine |
| 02/01/2012 | CN101247795B 用于治疗与中枢神经系统（cns）相关疾病的方法和组合物 A method for the treatment of central nervous system (cns) related diseases and compositions |
| 02/01/2012 | CN101238913B 一种有效截留重金属元素的卷烟滤嘴及其制造方法 Cigarette filter an effective retention of heavy metals in its manufacturing method |
| 02/01/2012 | CN101220374B 鸡痘病毒双基因表达载体（pg7.5n） FPV dual expression vector (pg7.5n) |
| 02/01/2012 | CN101214285B 虎杖提取物用于制备抗艾滋病毒和抗乙肝病毒产品的用途 Uses Polygonum cuspidatum extract used in the preparation of anti-HIV and anti-hepatitis B virus products |
| 02/01/2012 | CN101184482B 抑制胃酸分泌的组合物和其制备方法 Inhibition of gastric acid secretion and a composition for its preparation |
| 02/01/2012 | CN101175484B 可分散波生坦片剂 Dispersible tablets bosentan |
| 02/01/2012 | CN101129381B 含β-内酰胺类抗生素和离子螯合剂的抗生素复方 Contained within the β- lactam antibiotics and antibiotic ion chelating compound |
| 02/01/2012 | CN101124213B 磺酰氨基环状衍生物及其应用 Sulphonamido cyclic derivatives and its application |
| 02/01/2012 | CN101115744B 制备4-（6-氯-2，3-亚甲基二氧基苯胺基）-7-[2-（4-甲基哌嗪-1-基）乙氧基]-5-四氢吡喃-4-基氧基喹唑啉的方法、中间体及其晶状盐 Preparation of 4- (6-chloro-2,3-methylenedioxy-anilino) -7- [2- (4-methyl-piperazin-1-yl) ethoxy] -5-tetrahydropyran quinazoline-4-yloxy methods, intermediates and crystalline salts thereof |
| 02/01/2012 | CN101112423B 用于针刀中药植入疗法治疗颈、肩、腰、腿痛的药物组合物 Knife medicine implant therapy for the neck, shoulders, waist, leg pain pharmaceutical composition |
| 02/01/2012 | CN101084979B 一种用于癌症辅助治疗药物制剂及其制备方法 A cancer adjuvant therapy method for its preparation |
| 02/01/2012 | CN101068806B (s)-(-)-1-(4-氟代异喹啉-5-基）磺酰基-2-甲基-1,4-高哌嗪盐酸盐-二水合物 (S) - (-) - 1- (4- fluoro-isoquinolin-5-yl) sulfonyl-2-methyl-1,4-homopiperazine hydrochloride - dihydrate |
| 02/01/2012 | CN101068781B 用于阿尔茨海默氏病的化合物 Compounds for Alzheimer's disease |
| 02/01/2012 | CN101019824B 一种含有丹参丹酚酸a的口服药物组合物的制备方法 A method of preparing a Salvia Sal oral pharmaceutical compositions containing |
| 01/31/2012 | US8106233 Applying di-2-ethylhexyl 4-hydroxy-3,5-dimethoxy-benzylmalonate; protective action against UV rays, oxidative stress on body cells, counters skin ageing |
| 01/31/2012 | US8106221 Renin inhibitors |
| 01/31/2012 | US8106218 Pharmaceutical compounds |
| 01/31/2012 | US8106215 3-aza-bicyclo[3.3.0]octane compounds |
| 01/31/2012 | US8106214 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as PI3 kinase inhibitors |
| 01/31/2012 | US8106213 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/31/2012 | US8106212 Substituted enaminocarbonyl compounds |
| 01/31/2012 | US8106211 Substituted enaminocarbonyl compounds |
| 01/31/2012 | US8106209 Substituted aminothiazole prodrugs of compounds with anti-HCV activity |
| 01/31/2012 | US8106208 Benzamide compounds that act as NK receptor antagonists |
| 01/31/2012 | US8106207 Tricyclic δ-opioid modulators |
| 01/31/2012 | US8106197 Aminoheteroaryl compounds as protein kinase inhibitors |
| 01/31/2012 | US8106196 Dihydropyrimidine compounds and their uses in manufacture of a medicament for treatment and prevention of viral diseases |
| 01/31/2012 | US8106185 Agmatine or aminoguanidine and dextran hydroxypolymer, Tc-99m radionuclide, Farmorubicine anticancer drug, Tamoxifen; intravesically, regiolocally, peritoneally, intratumorally, systemically or intravenously administrable |
| 01/31/2012 | US8106181 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
| 01/31/2012 | US8106179 Small interfering RNA specific to sub-units α, α′and β of the Kinase Protein ck2, and the applications of the same |
| 01/31/2012 | US8106151 Polyquaternium-1 synthesis methods |
| 01/31/2012 | US8106099 2'-{[2-(4-methoxyphenyl)acetylamino]methyl}biphenyl-2-carboxylic acid (2-pyridin-3-ylethyl)amide or other phenylcarboxamide derivatives with dofetilide, ibutilide, almokalant, sotalol, azimilide, amiodarone, E4031, clofilium, ambasilide, MS551, tedisamil, bertosamil and quinidine as IKr chahel blocker |
| 01/31/2012 | US8106097 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 01/31/2012 | US8106096 Compositions and methods for treatment of optic nerve diseases |
| 01/31/2012 | US8106095 modulators of peroxisome proliferator activated receptors; treating diabetes, polycystic ovary syndrome, hypertension, ischemia, stroke, irritable bowel disorder, inflammation, cardiovascular diseases; dyslipidema; [4-[[2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]thio]-2-methylphenoxy]-acetic acid |
| 01/31/2012 | US8106094 Compositions and methods for treating skin conditions |
| 01/31/2012 | US8106093 Glycogen or polysaccharide storage disease treatment method |
| 01/31/2012 | US8106091 Inhibitors of IKK-beta serine-threonine protein kinase |
| 01/31/2012 | US8106090 Antidiabetic agents; prevent of non-insulin dependent diabetes |
| 01/31/2012 | US8106089 Reacting pyrrolylalkylcarbinole, furanylalkylcarbinole or thiophenylalkylcarbinole units; cyclodehydration, hydroboration, oxidation, palladium-catalyzed Suzuki-Miyaura cross-coupling; anticarcinogenic agents, antitumor, and antiproliferative agents; autoimmune and neurodegenerative diseases |
| 01/31/2012 | US8106088 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 01/31/2012 | US8106087 Spiro-oxindole compounds and their uses as therapeutic agents |
| 01/31/2012 | US8106086 Indoledione derivative |
| 01/31/2012 | US8106085 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/31/2012 | US8106084 Synthesis and anti-proliferative effect of benzimidazole derivatives |
| 01/31/2012 | US8106083 Triazole compounds that modulate HSP90 activity |
| 01/31/2012 | US8106082 Dual-acting antihypertensive agents |
| 01/31/2012 | US8106081 Combination of organic compounds useful for treating diabetes |
| 01/31/2012 | US8106080 Mixture of muscle relaxant and nitrogen oxide doner; promote cell muscle proliferation repair; muscle dystrophy therapy |
| 01/31/2012 | US8106079 Intermediate of 6-substituted-1-methyl-1-H-benzimidazole derivative and method for producing same |
| 01/31/2012 | US8106078 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/31/2012 | US8106077 Compounds and methods for modulating FXR |
| 01/31/2012 | US8106076 Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same |
| 01/31/2012 | US8106075 insecticide for representatives of the order Acarina; protection of plant propagation material from the attack by pests; N-(4-chloro-2-methyl-6-[([oxetan-2-ylmethyl]amino)carbonyl]phenyl)-1-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide |
| 01/31/2012 | US8106074 Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
| 01/31/2012 | US8106072 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative |
| 01/31/2012 | US8106070 Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 01/31/2012 | US8106069 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them |
| 01/31/2012 | US8106068 Compositions and methods for modulating c-kit and PDGFR receptors |
| 01/31/2012 | US8106067 Indolizine derivatives and the use thereof as antidiabetics |
| 01/31/2012 | US8106066 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
| 01/31/2012 | US8106065 Antitussive agent |
| 01/31/2012 | US8106064 Pyrimidine-2,4-dione HIV reverse transcriptase inhibitors |
| 01/31/2012 | US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 01/31/2012 | US8106062 Calcium channel blockers |
| 01/31/2012 | US8106061 Comprises 2-(2-propoxyphenyl)-8-azapurin-6-one (zaprinast); for treatment of benign prostatic hyperplasia and urination disorders |
| 01/31/2012 | US8106060 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals |
| 01/31/2012 | US8106059 Substituted pyrazines that inhibit protease cathepsin S and HCV replication |
| 01/31/2012 | US8106058 Anti-arenaviral compounds |
| 01/31/2012 | US8106057 Dihydroxyphenyl isoindolylmethanones |
| 01/31/2012 | US8106056 Combination preparations comprising bifeprunox and a dopamine agonist |
| 01/31/2012 | US8106055 Substituted amide compounds |
| 01/31/2012 | US8106054 Crystalline pyridazine compound |
| 01/31/2012 | US8106053 5-phenyl-3-pyridazinone derivative |
| 01/31/2012 | US8106052 Luminescence-based methods and probes for measuring cytochrome P450 activity |
| 01/31/2012 | US8106051 Utilities of amide compounds |
| 01/31/2012 | US8106050 Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications |
| 01/31/2012 | US8106049 Reverse-turn mimetics and method relating thereto |
| 01/31/2012 | US8106048 protozoal infestations in humans and animals, by bacteria, viruses or proteinaceous agents; neurological diseases or disorders; ischemia and/or reperfusion injury; 4-(4-Ethoxycarbonyl-4,5-dihydro-thiazol-2-yl)-piperidine-1-carboxylic acid t-butyl ester |
| 01/31/2012 | US8106047 (4-Methoxyphenyl)-[3-(4-methoxyphenyl)-[1,2,4]triazolo[3,4-a]phthalazin-6-yl]-amine; phosphodiesterase inhibitors; septic shock or vascular edema; neoangiogenesis or inflammatory disease |
| 01/31/2012 | US8106046 Cyclopentathiophene modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |